Form 8-K - Current report:
SEC Accession No. 0001171843-24-005098
Filing Date
2024-09-06
Accepted
2024-09-06 16:15:12
Documents
13
Period of Report
2024-09-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_090624.htm   iXBRL 8-K 23615
  Complete submission text file 0001171843-24-005098.txt   199724

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE apto-20240905.xsd EX-101.SCH 3009
3 XBRL LABEL FILE apto-20240905_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE apto-20240905_pre.xml EX-101.PRE 22355
15 EXTRACTED XBRL INSTANCE DOCUMENT f8k_090624_htm.xml XML 3915
Mailing Address 66 WELLINGTON STREET WEST, SUITE 5300 TD BANK TOWER BOX 48 TORONTO A6 M5K 1E6
Business Address 66 WELLINGTON STREET WEST, SUITE 5300 TD BANK TOWER BOX 48 TORONTO A6 M5K 1E6 310-849-8060
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32001 | Film No.: 241284685
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)